Multiple sclerosis affects women about three times more often than men, and the reasons trace back to a combination of genetics, hormones, immune system differences, and environmental exposures that interact in ways unique to the female body. No single cause explains MS in anyone, but several factors converge to make biological females significantly more vulnerable.
Why Women Are More Susceptible Than Men
The 3:1 female-to-male ratio in MS is one of the most striking sex differences in any neurological disease. This gap wasn’t always so wide. Over recent decades, the ratio has increased, suggesting that environmental and lifestyle factors are amplifying an already existing biological vulnerability in women. Understanding what drives that vulnerability starts with the X chromosome.
Women carry two X chromosomes, and to prevent a double dose of X-linked genes, one copy in each cell is supposed to be silenced. But this silencing isn’t perfect. Roughly 15% to 23% of genes on the “inactive” X chromosome escape this shutdown and remain active, producing extra proteins. The result is a patchwork of cells throughout the body where some express genes from both X chromosomes. In the immune system, this creates a more diverse and reactive population of immune cells. That diversity is useful for fighting infections, but it also raises the odds of the immune system mistakenly attacking the body’s own tissues, including the protective coating around nerve fibers in the brain and spinal cord.
How Hormones Shape MS Risk
Sex hormones like estrogen and progesterone don’t just regulate reproduction. They actively steer the immune system, influencing which types of immune cells dominate and how aggressively they respond. In MS, the immune system leans too heavily toward an inflammatory attack mode. Estrogen and progesterone help shift the balance toward a more protective, anti-inflammatory response. This is why the hormonal landscape at different life stages matters so much for MS.
Pregnancy offers the clearest example. As estrogen and progesterone levels climb through the second and third trimesters, many women with MS experience fewer relapses. The immune system essentially dials down its inflammatory activity to protect the pregnancy. After delivery, hormone levels drop rapidly, and relapse rates tend to climb back up. This postpartum rebound underscores how dependent MS activity can be on hormonal balance.
On the other end of the spectrum, menopause marks a turning point. A study published in Neurology found that menopause was an inflection point for accelerated worsening of physical and cognitive function in women with MS, even after adjusting for age, body weight, and smoking. Blood markers of nerve damage also rose faster after menopause. The loss of estrogen’s protective influence likely plays a central role in this shift, though aging itself also contributes.
Early Puberty and Increased Risk
The female-to-male gap in MS only becomes apparent after age 12, which points directly to puberty as a critical window. Multiple large studies have consistently found that girls who get their first period earlier face a higher risk of developing MS later in life. Each one-year delay in the onset of menstruation is associated with roughly a 10% to 11% reduction in MS risk. Girls who started menstruating at 12 rather than 13, for instance, carried measurably higher odds.
Earlier puberty also appears to influence when MS symptoms first appear. One study found that for every year later a girl reached menarche, the age of first MS symptoms was pushed back by more than a year. The likely explanation is that the hormonal surge of puberty reshapes the immune system during a period when the brain and spinal cord are still developing, creating a window of vulnerability. Earlier exposure to those hormonal shifts means more time spent in that vulnerable state.
The Epstein-Barr Virus Connection
Nearly all people with MS have been infected with Epstein-Barr virus, the common virus behind mononucleosis. While most people carry this virus without consequence, in genetically susceptible individuals it can set off a chain reaction in the immune system. The mechanism involves molecular mimicry: parts of a key viral protein share near-identical amino acid sequences with proteins found on nerve-insulating cells in the brain.
Specifically, a 47-amino-acid stretch within one of the virus’s proteins contains sequences that closely resemble three different molecules involved in nerve cell function. One of these mimicked proteins helps maintain the structure of nerve insulation. Another is a calcium-activated channel protein. When the immune system builds antibodies to fight the virus, those antibodies can also recognize and attack these lookalike proteins on nerve cells. This cross-reactivity doesn’t affect everyone who carries the virus, but in people with the right (or wrong) genetic makeup, it can trigger the autoimmune cascade of MS. While EBV infection rates are similar between men and women, the more reactive female immune system may be more prone to generating these cross-reactive responses.
Vitamin D Deficiency
Low vitamin D levels are consistently linked to higher MS risk, and women are particularly affected. A meta-analysis found that people with vitamin D deficiency, defined as blood levels below 50 nanomoles per liter, had a 54% higher risk of developing MS compared to those with sufficient levels. This threshold corresponds to about 20 nanograms per milliliter on the scale commonly used in the United States.
Several factors make women more likely to fall below this level. Women tend to have more indoor occupations, are more likely to use sunscreen consistently, and in some cultures cover more skin. Pregnancy and breastfeeding also deplete vitamin D stores. The geographic pattern of MS reinforces the vitamin D connection: the disease is far more common in northern latitudes where sunlight exposure is limited for much of the year.
Childhood Obesity and Body Weight
Being overweight during childhood and adolescence raises MS risk, and the effect is stronger in girls. Severely obese children have more than three times the likelihood of developing MS compared to children with a normal body weight. A Danish study found that girls whose body mass index was at or above the 95th percentile had a 1.75-fold higher risk of MS compared to girls below the 85th percentile.
Excess body fat influences MS risk through multiple pathways. Fat tissue produces inflammatory molecules that keep the immune system in a state of low-grade activation. It also stores and sequesters vitamin D, reducing the amount available in the bloodstream. And in girls, higher body fat is linked to earlier puberty, connecting back to the hormonal timing risk discussed above. These three mechanisms reinforce each other, which may explain why the effect is so pronounced.
Smoking
Smoking increases the risk of MS by roughly 40% to 50% compared to never smoking. An analysis estimating the population-level effect found an overall incidence rate ratio of 1.50 for ever-smokers versus never-smokers. Researchers have noted that parallel trends in smoking uptake among women and the rising female-to-male MS ratio over the 20th century reinforce the connection. As smoking became more common among women in the mid-1900s, the sex ratio in MS widened in the decades that followed, consistent with the years-long lag between exposure and disease onset.
Cigarette smoke irritates lung tissue and triggers immune activation in the airways. In genetically predisposed individuals, this chronic irritation may help prime immune cells to become autoreactive. Smoking also worsens disease progression in people who already have MS, accelerating the accumulation of disability over time.
How These Factors Work Together
No single cause produces MS. The disease emerges when enough risk factors overlap in the same person. A girl who carries certain immune-related genes, was infected with Epstein-Barr virus in adolescence, went through puberty early, had low vitamin D levels growing up in a northern climate, and was overweight during her teens faces a meaningfully higher combined risk than someone with just one or two of those factors. The X chromosome’s extra immune gene expression provides the biological foundation, hormonal shifts at puberty open the window, and environmental exposures like viral infection, low vitamin D, smoking, and obesity push the immune system toward the tipping point where it begins attacking nerve tissue.
This layered picture also explains why MS rates in women are still climbing in many countries. Several of the modifiable risk factors, including childhood obesity, earlier puberty (itself linked to rising body weight), and historically increasing smoking rates among women, have become more common over the past several decades. The genetic and chromosomal vulnerabilities haven’t changed, but the environmental pressures on top of them have intensified.